Signaling pathways
-
BA8870 c-Kit-IN-5-1Summary: c-Kit-IN-5 is a potent inhibitor. - BA8872 LabuxtinibSummary: Tyrosine kinase inhibitors.
- BA8873 SavolitinibSummary: Savolitinib (AZD-6094) is a highly potent selective, oral bioavailability inhibitor with ICs of 5nM and 3nM for c-Met and p-Met, respectively.
-
BA8874 DihexaSummary: Dihexa (PNB-0408), an oligopeptide reagent, is an orally active, blood-brain barrier permeable angiotensin IV analog. - BA8875 TerevalefimSummary: A stem cell growth factor (HGF) analog.
- BA8876 ZongertinibSummary: Zongertinib (BI1810631) is a potent, selective and tyrosine kinase inhibitor with values of 13nM and 579nM, respectively.
- BA8877 GlumetinibSummary: Glumetinib (SCC244) is a highly selective, orally bioavailable, ATP-competitive inhibitor.
- BA8878 NingetinibSummary: A potent orally bioavailable small molecule tyrosine kinase inhibitor.
- BA8879 BozitinibSummary: Bozitinib (PLB-1001) is a highly selective kinase inhibitor that crosses the blood-brain barrier.
- BA8880 CEP-40783Summary: CEP-40783 is a highly selective, orally active inhibitor.